PT3347002T - Tratamento de doença de alzheimer numa população particular de pacientes - Google Patents
Tratamento de doença de alzheimer numa população particular de pacientesInfo
- Publication number
- PT3347002T PT3347002T PT168451813T PT16845181T PT3347002T PT 3347002 T PT3347002 T PT 3347002T PT 168451813 T PT168451813 T PT 168451813T PT 16845181 T PT16845181 T PT 16845181T PT 3347002 T PT3347002 T PT 3347002T
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- particular patient
- patient population
- neurodegenerative disorders
- treating neurodegenerative
- Prior art date
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562216404P | 2015-09-10 | 2015-09-10 | |
| US201662290287P | 2016-02-02 | 2016-02-02 | |
| US201662302027P | 2016-03-01 | 2016-03-01 | |
| US201662365809P | 2016-07-22 | 2016-07-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3347002T true PT3347002T (pt) | 2023-07-27 |
Family
ID=58240195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT168451813T PT3347002T (pt) | 2015-09-10 | 2016-09-09 | Tratamento de doença de alzheimer numa população particular de pacientes |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11191742B2 (pt) |
| EP (2) | EP4275750A3 (pt) |
| JP (3) | JP6789579B2 (pt) |
| KR (2) | KR102412997B1 (pt) |
| CN (3) | CN116712423A (pt) |
| AU (1) | AU2016319107B2 (pt) |
| CA (1) | CA2997376C (pt) |
| DK (1) | DK3347002T3 (pt) |
| ES (1) | ES2952727T3 (pt) |
| FI (1) | FI3347002T3 (pt) |
| HK (1) | HK1257874A1 (pt) |
| HR (1) | HRP20230809T1 (pt) |
| HU (1) | HUE062511T2 (pt) |
| LT (1) | LT3347002T (pt) |
| MD (1) | MD3347002T2 (pt) |
| MX (2) | MX2018003023A (pt) |
| PL (1) | PL3347002T3 (pt) |
| PT (1) | PT3347002T (pt) |
| RS (1) | RS64481B1 (pt) |
| SI (1) | SI3347002T1 (pt) |
| WO (1) | WO2017044840A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3119911T3 (da) | 2014-03-21 | 2023-10-30 | Alzheon Inc | Forbindelser til anvendelse til behandling af alzheimers sygdom hos apoe4+/+ patienter |
| PL3347002T3 (pl) * | 2015-09-10 | 2023-11-13 | Alzheon, Inc. | Leczenie choroby alzheimera w konkretnej populacji pacjentów |
| CN108623501B (zh) | 2017-03-21 | 2022-04-19 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸衍生物及其用途 |
| CN110003058B (zh) | 2018-01-04 | 2022-01-25 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-3,3-二氘-1-丙磺酸晶型、制备方法及用途 |
| FI3829568T3 (fi) * | 2018-08-01 | 2023-12-04 | Alzheon Inc | Sulfopropaanihappojohdannaisia neurodegeneratiivisten sairauksien hoitamista varten |
| SG11202100767XA (en) * | 2018-08-01 | 2021-02-25 | Alzheon Inc | Methods for treating neurodegenerative disorders |
| CN111170901A (zh) * | 2018-11-13 | 2020-05-19 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-1-丙磺酸晶型、制备方法及其用途 |
| KR20220024434A (ko) | 2019-06-17 | 2022-03-03 | 알제온, 인크. | 신경퇴행성 장애를 치료하는 방법 |
| WO2023107658A1 (en) * | 2021-12-09 | 2023-06-15 | Alzheon, Inc. | Alz-801 for use in treating alzheimer's disease |
| WO2023150381A1 (en) * | 2022-02-07 | 2023-08-10 | Alzheon, Inc. | Alz-801 for use in treating a covid-19 associated neurological symptom |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| AU677614B2 (en) | 1992-10-13 | 1997-05-01 | Duke University | Methods of detecting Alzheimer's disease |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20060079578A1 (en) | 2003-06-23 | 2006-04-13 | Julie Laurin | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| AU2004304787A1 (en) | 2003-08-11 | 2005-07-07 | California Institute Of Technology | Microfluidic large scale integration |
| KR20070120190A (ko) | 2005-04-12 | 2007-12-21 | 뉴로켐 (인터내셔널) 리미티드 | 아밀로이드 억제 화합물의 제약 제제 |
| FI3851447T3 (fi) | 2006-10-12 | 2023-11-15 | Bellus Health Inc | Menetelmiä, yhdisteitä, koostumuksia ja vehikkeleitä 3-amino-1-propaanisulfonihapon vapauttamiseksi |
| SG173409A1 (en) | 2006-11-24 | 2011-08-29 | Ac Immune Sa | N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimers |
| JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| WO2012006329A2 (en) | 2010-07-06 | 2012-01-12 | Genomind, Llc | Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| MX353096B (es) | 2010-08-19 | 2017-12-19 | Buck Institute For Age Res Star | Metodos para tratar el deterioro cognitivo leve (mci) y trastornos relacionados. |
| PL2994160T3 (pl) | 2013-05-06 | 2019-10-31 | Baxalta Inc | Leczenie subpopulacji osób z chorobą alzheimera z użyciem połączonej immunoglobuliny g |
| RU2724190C2 (ru) | 2014-02-08 | 2020-06-23 | Дженентек, Инк. | Способы лечения болезни альцгеймера |
| DK3119911T3 (da) * | 2014-03-21 | 2023-10-30 | Alzheon Inc | Forbindelser til anvendelse til behandling af alzheimers sygdom hos apoe4+/+ patienter |
| PL3347002T3 (pl) * | 2015-09-10 | 2023-11-13 | Alzheon, Inc. | Leczenie choroby alzheimera w konkretnej populacji pacjentów |
-
2016
- 2016-09-09 PL PL16845181.3T patent/PL3347002T3/pl unknown
- 2016-09-09 HR HRP20230809TT patent/HRP20230809T1/hr unknown
- 2016-09-09 PT PT168451813T patent/PT3347002T/pt unknown
- 2016-09-09 CA CA2997376A patent/CA2997376C/en active Active
- 2016-09-09 RS RS20230603A patent/RS64481B1/sr unknown
- 2016-09-09 EP EP23176559.5A patent/EP4275750A3/en active Pending
- 2016-09-09 HU HUE16845181A patent/HUE062511T2/hu unknown
- 2016-09-09 LT LTEPPCT/US2016/051091T patent/LT3347002T/lt unknown
- 2016-09-09 JP JP2018512564A patent/JP6789579B2/ja active Active
- 2016-09-09 KR KR1020187009381A patent/KR102412997B1/ko active IP Right Grant
- 2016-09-09 SI SI201631729T patent/SI3347002T1/sl unknown
- 2016-09-09 CN CN202310582394.5A patent/CN116712423A/zh active Pending
- 2016-09-09 KR KR1020227009418A patent/KR102547164B1/ko active IP Right Grant
- 2016-09-09 MX MX2018003023A patent/MX2018003023A/es unknown
- 2016-09-09 EP EP16845181.3A patent/EP3347002B1/en active Active
- 2016-09-09 DK DK16845181.3T patent/DK3347002T3/da active
- 2016-09-09 CN CN202310582365.9A patent/CN116712422A/zh active Pending
- 2016-09-09 WO PCT/US2016/051091 patent/WO2017044840A1/en active Application Filing
- 2016-09-09 MD MDE20180700T patent/MD3347002T2/ro unknown
- 2016-09-09 FI FIEP16845181.3T patent/FI3347002T3/fi active
- 2016-09-09 CN CN201680052760.4A patent/CN108289870A/zh active Pending
- 2016-09-09 ES ES16845181T patent/ES2952727T3/es active Active
- 2016-09-09 AU AU2016319107A patent/AU2016319107B2/en active Active
- 2016-09-09 US US15/758,405 patent/US11191742B2/en active Active
-
2018
- 2018-03-09 MX MX2022003128A patent/MX2022003128A/es unknown
-
2019
- 2019-01-07 HK HK19100235.4A patent/HK1257874A1/zh unknown
-
2020
- 2020-09-28 JP JP2020161995A patent/JP7128536B2/ja active Active
-
2021
- 2021-09-17 US US17/477,886 patent/US20220096406A1/en not_active Abandoned
-
2022
- 2022-08-12 JP JP2022128786A patent/JP2022145949A/ja active Pending
-
2023
- 2023-09-06 US US18/462,238 patent/US20230414541A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1257874A1 (zh) | 治療特定患者群體之神經退行性疾病的方法 | |
| IL285151A (en) | Methods for the treatment of fgf21-related disorders | |
| HK1231417A1 (zh) | 用於治療眼科疾病和障礙的化合物 | |
| HK1245078A1 (zh) | 治療神經退行性疾病的方法 | |
| HK1259336A1 (zh) | 用於治療骨髓增生性病症的方法 | |
| SG11201703193XA (en) | Treatment for depression and depressive disorders | |
| IL279308A (en) | Methods for the treatment of heptidine-mediated disorders | |
| HK1256036A1 (zh) | 治療骨髓增生性障礙的方法 | |
| IL269106A (en) | Methods for the treatment of neurodegenerative diseases | |
| IL264641A (en) | Acetyl-leucine for use in the treatment of neurodegenerative diseases | |
| HK1245127A1 (zh) | 治療腦疾病的方法和組合物 | |
| GB201516905D0 (en) | Treatment of Neurodegenerative diseases | |
| ZA201606673B (en) | Compositions and methods for treating neurodegenerative diseases | |
| GB201408387D0 (en) | Treatment of respiratory disorders | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| HK1243937A1 (zh) | 治療疾病的方法 | |
| GB201411616D0 (en) | Diagnosis and treatment of neurodegenerative disorders | |
| GB201602011D0 (en) | Treating skin disorders | |
| GB201602784D0 (en) | New treatment of CFTR-related disorders | |
| GB201413532D0 (en) | Combination therapy for treating hearing disorders | |
| GB201506944D0 (en) | Therapeutic treatment |